İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

MEHMET MURAT KIŞLA

ARAŞTIRMA GÖREVLİSİ

ANKARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 26
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 11 Q2 4 Q3 11 Q4 0
WoS (JCR) Q1 4 Q2 10 Q3 5 Q4 5
TR Index 6 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 6
Ort. yüzdelik 63.7%
Üst %1 payı 0.0%
Üst %10 payı 25.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 26 yayın

Scopus (SJR)
Q1 11 Q2 4 Q3 11 Q4 0
WoS (JCR)
Q1 4 Q2 10 Q3 5 Q4 5
TR Index
6 makale

Makale listesi

  1. 2025 Rhoifolin: A promising flavonoid with potent cytotoxic and anticancer properties: molecular mechanisms and therapeutic potential. EXCLI journal DOI 10.17179/excli2024-7836 YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.9%
  2. 2025 RHOIFOLIN: A PROMISING FLAVONOID WITH CYTOTOXIC AND ANTICANCER PROPERTIES - MOLECULAR MECHANISMS AND THERAPEUTIC POTENTIAL EXCLI Journal DOI 10.17179/excli2024-7836 YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.8%
  3. 2025 Antibacterial, Antifungal and Molecular Docking Studies of N1‐Substituted 5‐Alkylsulfonyl Benzimidazole Derivatives Helvetica Chimica Acta DOI 10.1002/hlca.202500014 YÖKSİS SJR Q2 JCR Q3 OpenAlex 10.4%
  4. 2025 RHOIFOLIN: A PROMISING FLAVONOID WITH CYTOTOXIC AND ANTICANCER PROPERTIES - MOLECULAR MECHANISMS AND THERAPEUTIC POTENTIAL EXCLI JOURNAL DOI 10.17179/excli2024-7836 YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.8%
  5. 2024 Synthesis and Structure of Novel Phenothiazine Derivatives, and Compound Prioritization via In Silico Target Search and Screening for Cytotoxic and Cholinesterase Modulatory Activities in Liver Cancer Cells and In Vivo in Zebrafish ACS omega DOI 10.1021/acsomega.3c06532 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.7%
  6. 2024 Synthesis, Anticancer Activity, and In Silico Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer ACS Omega DOI 10.1021/acsomega.3c09411 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  7. 2024 Synthesis, Anticancer Activity, and In Silico Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer ACS Omega DOI 10.1021/acsomega.3c09411 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  8. 2024 Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia Medicinal Chemistry DOI 10.2174/0115734064311341240929175508 YÖKSİS SJR Q3 JCR Q3 OpenAlex 60.5%
  9. 2024 Synthesis and Structure of Novel Phenothiazine Derivatives, and Compound Prioritization via In Silico Target Search and Screening for Cytotoxic and Cholinesterase Modulatory Activities in Liver Cancer Cells and In Vivo in Zebrafish ACS Omega DOI 10.1021/acsomega.3c06532 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.4%
  10. 2024 Synthesis, Anticancer Activity, and In Silico Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer ACS Omega DOI 10.1021/acsomega.3c09411 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  11. 2023 Incorporation of Protecting Groups in Organic Chemistry: A Mini-Review Current Organic Synthesis DOI 10.2174/1570179419666220820152723 YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.3%
  12. 2022 Synthesis, antioxidant activity, molecular docking and ADME studies of novel pyrrolebenzimidazolederivatives The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS DOI 10.55730/1300-0527.3377 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 39.3%
  13. 2022 Synthesis, antioxidant activity, molecular docking and ADME studies of novel pyrrolebenzimidazolederivatives Turkish Journal of Chemistry DOI 10.55730/1300-0527.3377 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 39.3%
  14. 2022 Synthesis, antioxidant activity, molecular docking and ADME studies of novel pyrrolebenzimidazolederivatives Turkish Journal of Chemistry DOI 10.55730/1300-0527.3377 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 39.3%
  15. 2022 Benzimidazoles Against Certain Breast Cancer Drug Targets: A Review Bentham Science Publishers Ltd. DOI 10.2174/1389557522666220328161217 YÖKSİS SJR Q2 JCR Q2 OpenAlex 53.2%
  16. 2022 Incorporation of Protecting Groups in Organic Chemistry: A Mini-Review Current Organic Synthesis DOI 10.2174/1570179419666220820152723 YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.3%
  17. 2022 Benzimidazoles Against Certain Breast Cancer Drug Targets: A Review Mini-Reviews in Medicinal Chemistry DOI 10.2174/1389557522666220328161217 YÖKSİS SJR Q2 JCR Q2 OpenAlex 53.2%
  18. 2022 Incorporation of Protecting Groups in Organic Chemistry: A Mini-Review Current Organic Synthesis DOI 10.2174/1570179419666220820152723 YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.3%
  19. 2022 Synthesis, antioxidant activity, molecular docking and ADME studies of novel pyrrolebenzimidazolederivatives TÜBİTAK Turkish Journal of Chemistry DOI 10.55730/1300-0527.3377 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 39.3%
  20. 2021 Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives Medicinal Chemistry DOI 10.2174/1573406416666200420080459 YÖKSİS SJR Q3 JCR Q4 OpenAlex 41.3%

Akademisyenlere dön